Robert W. Buchanan MD
Professor, Psychiatry, University of Maryland School of Medicine
Join to View Full Profile
Spring Grove Hospital GroundsMaple and Locust StreetsCatonsville, MD 21228
Phone+1 410-402-7876
Fax+1 410-402-7198
Dr. Buchanan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
George Washington UniversityResidency, Psychiatry, 1980 - 1984
Rutgers New Jersey Medical SchoolClass of 1980
Certifications & Licensure
MD State Medical License 1984 - 2026
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine Start of enrollment: 2001 Dec 01
- Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia Start of enrollment: 2002 May 01
- Rasagiline in the Treatment of Persistent Negative Symptoms of Schizophrenia Start of enrollment: 2007 Jan 01
Publications & Presentations
PubMed
- Multivariate relationships between social cognitive performance and functional connectivity during task and rest across schizophrenia spectrum disorders and healthy co...Lindsay D Oliver, Ju-Chi Yu, Colin Hawco, Navona Calarco, Vinh Tan
Molecular Psychiatry. 2026-03-12 - A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine Utilization.Deanna L Kelly, Jared Hunt, Gopal Vyas, Matthew Glassman, Clayton H Brown
Schizophrenia Bulletin. 2026-03-07 - Randomized double-blind inpatient study of a gluten-free diet for negative symptoms in people with schizophrenia.Deanna L Kelly, Christopher M Lee, Gopal Vyas, Robert W Buchanan, Daniel J Roche
Schizophrenia Research. 2026-03-01
Lectures
- Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...UC Davis Health System, Sacramento, California - 9/13/2012
Other
- Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...Robert Buchanan, MD, Schizophrenia Bulletin
https://www.doximity.com/articles/19cb6ea7-83a0-45e3-8fd1-8be0f0ddd718
UpToDate, Wolters Kluwer Health - 2011-10-10 - Lower- and Higher-Level Social Cognitive Factors Across Individuals with Schizophrenia Spectrum Disorders and Healthy Controls: Relationship with Neurocognition and Fu...Robert Buchanan, MD, Schizophrenia Bulletin
https://www.doximity.com/articles/19cb6ea7-83a0-45e3-8fd1-8be0f0ddd718
UpToDate, Wolters Kluwer Health - 2012-11-08
Press Mentions
Polypharmacy in Psychiatry: Good, Bad, or Just Unavoidable?March 7th, 2025
Treating Schizophrenia SuccessfullyOctober 8th, 2018
UM SOM Professor of Psychiatry Recognized for Innovative and Promising Research in SchizophreniaOctober 31st, 2017
Grant Support
- Assessment CoreNational Institute Of Mental Health1998–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
